BIOEDGE

Biological EDGE

Buy Now

“Meticulous research. Penetrating analysis. A solid framework for change.”  — Dr. Michael J. Krentz

Biological EDGE

Biohacking Starts With NO

Buy Now

“I used to override my body. Now I listen. The difference is stunning.”— Michael Broder

Biohacking Starts With NO
Men's Health

Men's Health Library

Every article, presentation, spotlight, and news item we've tagged to Men's Health.

AllLibraryArticlesPresentationsSpotlightsNews

Featured Library

View all library
PresentationFeb 11, 2026

The 800lb Gorilla: How EDCs Are Destroying Your Hormones

Carlos Bertonatti and Dr. Rudolph Eberwein from Medical Health Institute confront an urgent crisis in modern health: endocrine-disrupting chemicals (EDCs) are systematically destroying hormonal health across all age groups. This panel discussion tackles the "800-pound gorilla" that the functional medicine community often avoids—the root cause of widespread testosterone deficiency affecting men as young as 18. Drawing from their Miami-based hormone optimization clinic, they expose how changing demographics of hypogonadism reveal a generation under siege from environmental toxins, and why addressing this crisis demands immediate action from the biohacking community.

ArticleJan 24, 2026

Why Your Hormones Hold the Key to Thriving Through Midlife

Discover how adaptogenic herbs and alkaline nutrition can transform your midlife experience. Dr. Anna Cabeca's functional approach helps women navigate hormonal shifts with energy, clarity, and confidence.

PresentationFeb 9, 2026

Anna Cabeca Menopause Mood and Mojo

Join Dr. Anna Cabeca, founder of The Girlfriend Doctor, for an empowering session on reclaiming vitality during menopause. Discover how hormonal optimization can transform your mood, energy, and overall well-being during midlife transitions. Dr. Cabeca will share evidence-based strategies for balancing hormones naturally, addressing common challenges like brain fog, weight gain, and emotional fluctuations. Learn practical biohacking techniques to not just survive menopause, but thrive through it with renewed confidence and vitality.

News

View all news
Peter Attia MDApr 18, 2026

Prostate cancer: a PSA on PSA

Prostate-specific antigen (PSA) screening remains an underutilized tool for early prostate cancer detection despite proven capacity to identify disease at more treatable stages. The clinical evidence supports selective screening in men at appropriate risk, yet implementation barriers persist in clinical practice.

Wiley Aging CellMay 5, 2026

From “Passive Supplementation” to “Active Repair”: Melatonin Reshapes the Treatment Paradigm for Late‐Onset Hypogonadism by Targeting Leydig Cell Senescence

Melatonin restores testosterone production in aging Leydig cells by addressing oxidative stress and mitochondrial dysfunction, offering a mechanism-based alternative to passive testosterone supplementation. This shift from symptom management to cellular repair has implications for age-related hormonal decline in men.

Nature - npj AgingApr 18, 2026

Global stagnation and misaligned priorities in BPH drug development: a 25-year landscape analysis of clinical trial registries

Benign prostatic hyperplasia drug development has stagnated over 25 years, with clinical trial pipelines showing minimal innovation and priorities misaligned with patient burden. This stagnation reflects a broader market failure in addressing age-related conditions that affect quality of life and functional independence in aging populations.

Peter Attia MDApr 20, 2026

#388 — Prostate cancer screening: why current PSA guidelines are failing men and how modern tools improve early detection and save lives

Current PSA-based prostate cancer screening protocols miss clinically significant cancers and fail to distinguish aggressive from indolent disease, reducing detection effectiveness. Modern biomarkers and imaging technologies enable earlier identification of aggressive tumors when intervention is most effective, fundamentally altering outcomes for men at risk.

Wiley Aging CellApr 16, 2026

Endothelial Sirtuins and Mitochondrial Function Are Associated With Testosterone Status: Implications for Accelerated Vascular Aging in Middle‐Age and Older Men With Low Testosterone

Middle-aged and older men with low testosterone demonstrate reduced mitochondrial respiration and decreased SIRT3 expression in vascular endothelial cells, indicating accelerated vascular aging through impaired oxidative stress regulation. This mechanism links testosterone deficiency directly to cardiovascular disease risk through mitochondrial dysfunction.

Wiley Aging CellMay 3, 2026

Loss of Chromosome Y Associates With Altered Immune Cell Trajectories and X‐Inactivation Features

Loss of chromosome Y in male leukocytes, detected in nearly 9% of cells in older men, produces cell-type-specific immune dysfunction characterized by altered monocyte differentiation and aberrant X-chromosome inactivation patterns. These molecular changes associate with increased risk for cardiovascular disease and cancer, suggesting LOY represents a meaningful driver of age-related immune decline in men rather than a neutral age-related marker.

Longevity.TechnologyApr 6, 2026

Catalyst Precision Health debuts at-home men’s longevity care

Catalyst Precision Health launches an integrated model combining in-home testing, physician house calls, and continuous personalized care for men's longevity, addressing fragmentation in the current market where health data remains scattered across disconnected providers and platforms.

Longevity.TechnologyMar 23, 2026

Stop treating women as an exception in aging science

Aging science built primarily on male biology has systematically misunderstood female physiology, leading to ineffective or harmful optimization strategies for women. A female-centered approach recognizes that women's hormonal cycles are rhythmic rather than erratic, and that sex-based differences in metabolism, hormone production, and social bonding represent distinct biological advantages requiring tailored intervention.

Longevity.TechnologyApr 9, 2026

Erectile dysfunction drugs and longevity

PDE5 inhibitors, established drugs for erectile dysfunction, are attracting early interest in longevity medicine for their capacity to improve vascular function and tissue resilience through nitric oxide signaling—not by targeting root causes of aging, but by supporting system performance under the stress of accumulated damage.

LT WireFeb 4, 2026

Acorn Biolabs treats first patients in randomized hair regeneration trial

Acorn Biolabs has initiated a randomized, controlled trial of YOU, an autologous secretome derived from hair follicle stem cells, to treat androgenic alopecia. The study will measure changes in hair density, thickness, and patient outcomes against placebo, establishing whether personalized regenerative approaches offer clinically meaningful advantages over existing pharmacologic treatments.